Current Environment: Production

David Whiting | Medical Services

Programs & Services

Languages

  • English

David Whiting | Education

Medical School

New York University School of Medicine

1999, New York, NY

Internship

General Surgery

University of California at Los Angeles

1999, Los Angeles, CA

Residency

General Surgery

University of California at Los Angeles

2000, Los Angeles, CA

Residency

Anesthesiology

University of Pittsburgh

2004, Pittsburgh, PA

Fellowship

Research, Cardiothoracic Surgery

University of California, Los Angeles Medical Center

Los Angeles, CA

Fellowship

Pediatric Anesthesiology

Boston Children's Hospital

2007, Boston, MA

Fellowship

Pediatric Cardiac Anesthesiology

Boston Children's Hospital

Boston, MA

David Whiting | Certifications

  • American Board of Anesthesiology (General)
  • American Board of Anesthesiology (Pediatric Anesthesiology)

David Whiting | Publications

  1. Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement. J Extra Corpor Technol. 2016 Mar; 48(1):39-42. View Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement. Abstract

  2. Cardiopulmonary bypass in the pediatric population. Best Pract Res Clin Anaesthesiol. 2015 Jun; 29(2):241-56. View Cardiopulmonary bypass in the pediatric population. Abstract

  3. TEG and ROTEM: technology and clinical applications. Am J Hematol. 2014 Feb; 89(2):228-32. View TEG and ROTEM: technology and clinical applications. Abstract

  4. Case report: postoperative analgesia and preserved motor function with clonidine and buprenorphine via a sciatic perineural catheter. J Clin Anesth. 2009 Jun; 21(4):297-9. View Case report: postoperative analgesia and preserved motor function with clonidine and buprenorphine via a sciatic perineural catheter. Abstract

  5. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol. 1999 Oct; 41(4):555-63. View Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. Abstract

  6. A Kiswahili version of the SF-36 Health Survey for use in Tanzania: translation and tests of scaling assumptions. Qual Life Res. 1999; 8(1-2):101-10. View A Kiswahili version of the SF-36 Health Survey for use in Tanzania: translation and tests of scaling assumptions. Abstract

  7. Validation of the Kiswahili version of the SF-36 Health Survey in a representative sample of an urban population in Tanzania. Qual Life Res. 1999; 8(1-2):111-20. View Validation of the Kiswahili version of the SF-36 Health Survey in a representative sample of an urban population in Tanzania. Abstract

BESbswy